MX2009007413A - Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos. - Google Patents
Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos.Info
- Publication number
- MX2009007413A MX2009007413A MX2009007413A MX2009007413A MX2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A MX 2009007413 A MX2009007413 A MX 2009007413A
- Authority
- MX
- Mexico
- Prior art keywords
- derivatives
- quinolone
- quinolone carboxylic
- processes
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 6
- -1 Quinolone carboxylic acids Chemical class 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 abstract 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229940124307 fluoroquinolone Drugs 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/626,397 US7632944B2 (en) | 2007-01-24 | 2007-01-24 | Quinolone carboxylic acids, derivatives thereof, and methods of making and using same |
| PCT/US2008/050865 WO2008091752A2 (en) | 2007-01-24 | 2008-01-11 | Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009007413A true MX2009007413A (es) | 2009-07-17 |
Family
ID=39410211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009007413A MX2009007413A (es) | 2007-01-24 | 2008-01-11 | Acidos quinolona carboxilicos, derivados de los mismos, y metodos de fabricacion y uso de los mismos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7632944B2 (enExample) |
| EP (1) | EP2114915A2 (enExample) |
| JP (1) | JP2010516775A (enExample) |
| KR (1) | KR20090118027A (enExample) |
| CN (1) | CN101595101A (enExample) |
| AU (1) | AU2008209416B2 (enExample) |
| BR (1) | BRPI0806581A2 (enExample) |
| CA (2) | CA2674543C (enExample) |
| MX (1) | MX2009007413A (enExample) |
| WO (1) | WO2008091752A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090054406A1 (en) * | 2007-08-21 | 2009-02-26 | Ward Keith W | Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones |
| US8415342B2 (en) * | 2008-10-29 | 2013-04-09 | Bausch & Lomb Incorporated | Besifloxacin ophthalmic composition for the treatment or control of infection |
| BR122020021551B1 (pt) | 2008-11-15 | 2021-09-21 | Melinta Subsidiary Corp | Composição farmacêutica antimicrobiana e seu uso |
| US8481526B2 (en) * | 2009-03-25 | 2013-07-09 | Bausch & Lomb Incorporated | Fluoroquinolone carboxylic acid molecular crystals |
| NL2004142C2 (nl) | 2010-01-25 | 2011-07-26 | Mci Mirror Controls Int Nl Bv | Buitenspiegeleenheid, spiegeldrager, werkwijze voor montage van een buitenspiegeleenheid. |
| US10167271B2 (en) | 2015-01-28 | 2019-01-01 | Mankind Pharma Ltd | Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride |
| CN107880023B (zh) * | 2017-11-10 | 2021-02-19 | 西南大学 | 氟喹诺酮类胺基衍生物及其用途 |
| CN112159355B (zh) * | 2020-09-25 | 2022-06-24 | 西南大学 | 对氨基水杨酸氟喹诺酮类衍生物及其中间体、制备方法和应用 |
| CN112159354B (zh) * | 2020-09-25 | 2022-07-05 | 西南大学 | 对氨基水杨酸的氟喹诺酮类衍生物及其中间体、制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1086735A (en) * | 1977-11-03 | 1980-09-30 | John C. Danilewicz | Piperidino-quinazolines |
| EP0230946A3 (en) | 1986-01-20 | 1988-09-07 | Kyorin Pharmaceutical Co., Ltd. | Process for the preparation of quinolonecarboxylic acid derivatives |
| JPS63132885A (ja) | 1986-11-25 | 1988-06-04 | Hokuriku Seiyaku Co Ltd | キノリン−３−カルボン酸誘導体 |
| JPS63196580A (ja) | 1987-02-09 | 1988-08-15 | Hokuriku Seiyaku Co Ltd | キノリン−３−カルボン酸誘導体 |
| JPS63196579A (ja) | 1987-02-09 | 1988-08-15 | Hokuriku Seiyaku Co Ltd | キノリン−３−カルボン酸誘導体 |
| JP2613139B2 (ja) | 1990-07-19 | 1997-05-21 | エスエス製薬 株式会社 | キノロンカルボン酸誘導体 |
| TW222272B (enExample) | 1992-05-26 | 1994-04-11 | Ss Seiyaku Kk | |
| US5527910A (en) | 1992-12-30 | 1996-06-18 | Cheil Foods & Chemicals, Inc. | Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria |
| TW301607B (enExample) * | 1993-03-09 | 1997-04-01 | Takeda Pharm Industry Co Ltd | |
| FR2706459B1 (fr) | 1993-06-17 | 1995-08-04 | Bouchara Sa | Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent. |
| EP0931078B1 (en) * | 1996-09-13 | 2006-11-15 | Schering Corporation | Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase |
| US6685958B2 (en) | 2001-04-25 | 2004-02-03 | Insite Vision Incorporated | Quinolone carboxylic acid compositions and related methods of treatment |
| US6699492B2 (en) | 1999-03-31 | 2004-03-02 | Insite Vision Incorporated | Quinolone carboxylic acid compositions and related methods of treatment |
| JP4612301B2 (ja) * | 2003-12-26 | 2011-01-12 | 広栄化学工業株式会社 | １−アルキル−４−アミノメチルピペリジンの製造法 |
| DE102004035203A1 (de) * | 2004-07-21 | 2006-02-16 | Bayer Healthcare Ag | Substituierte Chinolone |
-
2007
- 2007-01-24 US US11/626,397 patent/US7632944B2/en not_active Expired - Fee Related
-
2008
- 2008-01-11 WO PCT/US2008/050865 patent/WO2008091752A2/en not_active Ceased
- 2008-01-11 CA CA2674543A patent/CA2674543C/en not_active Expired - Fee Related
- 2008-01-11 BR BRPI0806581-0A patent/BRPI0806581A2/pt not_active IP Right Cessation
- 2008-01-11 EP EP08705887A patent/EP2114915A2/en not_active Withdrawn
- 2008-01-11 JP JP2009547352A patent/JP2010516775A/ja active Pending
- 2008-01-11 CN CNA2008800031182A patent/CN101595101A/zh active Pending
- 2008-01-11 MX MX2009007413A patent/MX2009007413A/es active IP Right Grant
- 2008-01-11 AU AU2008209416A patent/AU2008209416B2/en not_active Ceased
- 2008-01-11 KR KR1020097015534A patent/KR20090118027A/ko not_active Ceased
- 2008-01-11 CA CA2790690A patent/CA2790690A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2114915A2 (en) | 2009-11-11 |
| JP2010516775A (ja) | 2010-05-20 |
| WO2008091752A3 (en) | 2008-10-16 |
| WO2008091752A2 (en) | 2008-07-31 |
| US20080176834A1 (en) | 2008-07-24 |
| CN101595101A (zh) | 2009-12-02 |
| US7632944B2 (en) | 2009-12-15 |
| CA2674543C (en) | 2012-12-04 |
| CA2674543A1 (en) | 2008-07-31 |
| AU2008209416B2 (en) | 2013-05-09 |
| CA2790690A1 (en) | 2008-07-31 |
| AU2008209416A1 (en) | 2008-07-31 |
| KR20090118027A (ko) | 2009-11-17 |
| BRPI0806581A2 (pt) | 2014-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009003313A (es) | Acidos quinolona carboxilicos, derivados de los mismos, procesos para su preparacion y su uso como agentes antibacterianos. | |
| WO2008091752A3 (en) | Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents | |
| AU2015221439B2 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same | |
| WO2012122340A8 (en) | Soluble guanylate cyclase activators | |
| GEP20217235B (en) | Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds | |
| GEP20135919B (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors | |
| EP4252848A3 (en) | Oxysterols and methods of use thereof | |
| MX2010003155A (es) | Derivados de ciclopropil aril amida y uso de los mismos. | |
| WO2016134301A3 (en) | Neuroactive steroids, compositions, and uses thereof | |
| EP4609866A3 (en) | Oxysterols and methods of use thereof | |
| EP4616908A3 (en) | Oxysterols and methods of use thereof | |
| TN2018000395A1 (en) | New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| PH12013500301A1 (en) | Oxadiazole inhibitors of leukotriene production | |
| MX2010007587A (es) | Compuestos que comprenden un grupo ciclobutoxi. | |
| SG10201806565SA (en) | Heterocyclic carboxylic acids as activators of soluble guanylate cyclase | |
| MY173448A (en) | Phenyl and benzodioxinly substituted indazoles derivatives | |
| MX2011012122A (es) | Derivados de tiofeno. | |
| EP4316591A3 (en) | Oxysterols and methods of use thereof | |
| WO2012004396A3 (en) | Process of preparing a thrombin specific inhibitor | |
| WO2017177004A8 (en) | Tertiary amides and method of use | |
| PH12012501052A1 (en) | Novel spiropiperidine compounds | |
| WO2011159124A3 (ko) | Ｉｎｔｅｒｌｅｕｋｉｎ-６ 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 | |
| EP4477222A3 (en) | Crystalline 4-(5-chloro-2-isopropylaminopyridin-4-yl)-1h-pyrrole-2-carboxylic acid [1-(3-chlorophenyl)-2-hydroxyethyl]amide hydrochloride salt | |
| WO2007032028A8 (en) | Thiazolinones and oxazolinones and their use as ptp1b inhibitors | |
| WO2011008666A3 (en) | 3-phenoxymethylpyrrolidine compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |